The Effect of Internet- and Mobile-based Group Treatment in Menopausal Women
IMGTMP
Internet- and Mobile-based Group Treatment of Menopausal and Psychological Health of Chinese Women: a Study Protocol for a Randomized Non-inferiority Trial
1 other identifier
interventional
140
1 country
1
Brief Summary
Background: Menopause syndrome generally occurs with and is related to psychological problems. However, Internet- and mobile-based group treatment (imGT) may improve women's physiological and psychological conditions. Objective: To investigate the efficacy of group treatment with or without Internet- and mobile-based treatment of menopause, mood swings and quality of life status. Methods: This protocol is for a randomized controlled clinical trial with a sample of 144 menopausal women divided into 2 groups: imGT and face-to-face group treatment (ffGT). The primary outcome will be the menopausal symptom improvement of the two groups, as assessed by Greene Climacteric Scale. The secondary outcomes will be quality of life, assessed by the Short Form 36 Health Survey Questionnaire; insomnia, assessed by the Pittsburgh Sleep Quality Inventory; anxiety, assessed by the Hamilton Anxiety Rating Scale; and therapeutic alliance, assessed by the Working Alliance Inventory-Short Revised. imGT will be performed once a week for 1.5 hours for 10 weeks with a daily Punched-in on the WeChat App; ffGT will be performed once a week for 1.5 hours for 10 weeks. All outcomes will be assessed at baseline, at a post-intervention evaluation (week 10), and at a follow-up evaluation (week 22). Discussion: This study will be the first clinical trial to examine the effects of imGT on menopausal women in China. If imGT is found to be equivalent to or superior to ffGT, it will facilitate easier access to menopausal health services, which may be feasible to offer to other medical institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 9, 2019
CompletedFirst Posted
Study publicly available on registry
May 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedMay 14, 2019
May 1, 2019
1.8 years
May 9, 2019
May 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Greene Climacteric Scale
Greene Climacteric Scale is used for evaluating menopausal symptoms. It contains 21 questions covering 5 domains: anxiety, depression, somatic symptoms, vasomotor symptoms, and sexual function. Each question is answered on a 4-point Likert scale. The answers to all 21 questions are summed to give a total quality-of-life measure; a higher score indicates a worse quality of life. According to the hypothesis and PRO-specific domains of this trial, vasomotor symptoms, anxiety and depression will be analysed specifically. The Chinese version of this questionnaire has a high validation (0.90), and the Cronbach's alpha coefficient is 0.95, while its test-retest reliability is 0.94 (P \<0.01).
week 0
Greene Climacteric Scale
Menopause symptoms after 10 sessions of group cognitive behavioral therapy
week 10
Greene Climacteric Scale
Menopause symptoms of one follow-up meeting
week 22
Secondary Outcomes (12)
The Short Form 36 Health Survey Questionnaire
week 0
The Short Form 36 Health Survey Questionnaire
week 10
The Short Form 36 Health Survey Questionnaire
week 22
Pittsburgh Sleep Quality Index
week 0
Pittsburgh Sleep Quality Index
week 10
- +7 more secondary outcomes
Study Arms (2)
Internet- and mobile-based group treatment
EXPERIMENTALthe therapy consists of 10 modules (15 hours in total) in groups of 8 participants each over a period of 10 weeks and one follow-up meeting (2 hours) 12 weeks after the 10th module (week 22). Each module is adapted from the previous literature on CBT rationale and will be conducted online on WeChat, a mobile social networking software with 1 billion users in 2018. First, we will establish a WeChat group containing the imGT group members and psychiatrists, in which everyone can talk instantly. The interactive treatments will be conducted every Friday evening for a duration of 1.5 hours via text, audio or video messaging.
Face-to-face group treatment
ACTIVE COMPARATOR10 modules will be conducted every weekend in the psychological counseling room of The Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University.
Interventions
First, we will establish a WeChat group containing the imGT group members and psychiatrists, in which everyone can talk instantly. The interactive treatments will be conducted every Friday evening for a duration of 1.5 hours via text, audio or video messaging. Table 1 summarizes the module topics and provides detailed information on the treatment program. All modules will be saved for repeated viewing after completion. Second, we will establish another WeChat program named Punched-in which participants report on aspects of their everyday life such as diet, sports, readings or mood, according to the plan made by psychiatrists, via text, audio, photo or video message. This program will only be visible to and able to be commented on by participants and psychiatrists.
Eligibility Criteria
You may qualify if:
- aged 40\~60, in menopausal transition or post-menopause, according to the STRAW +10 definition
- have Internet access
- have mobile phone access
- have sufficient knowledge of the Chinese language
- have scored in the clinical range for menopause syndrome from the psychiatric interview
- have signed a consent form that will be provided to eligible participants.
You may not qualify if:
- not completing informed consent
- presence of any of the following diseases: hyperthyroidism, coronary atherosclerotic heart disease, hypertension (BP≥140/90 mmHg), pheochromocytoma, neurasthenia, psychosis, or other diseases closely related to the main disease
- troublesome drinking
- drug use (hypnotics or hormone therapy) in the past 14 days, which might affect mood.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210000, China
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Ms Kong, Master
the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 9, 2019
First Posted
May 13, 2019
Study Start
June 1, 2018
Primary Completion
March 31, 2020
Study Completion
August 31, 2020
Last Updated
May 14, 2019
Record last verified: 2019-05